Search Results 1111-1120 of 21353 for anti-TNF drugs

  1. Telmisartan (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Butalbital, Acetaminophen, Caffeine, And Codeine (Oral Route) Description and Brand Names - Mayo Clinic

    It has also been used for migraine headaches. Codeine belongs to the group of medicine called narcotic analgesics (pain medicines). It acts on the central ...

  3. Epoetin Alfa (Injection Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Estradiol (Transdermal Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Ipratropium (Nasal Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. Use this medicine only as directed by your doctor . Do not use more of it ...

  6. Sulfonamide (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Sulfonamides, or sulfa medicines, belong to the family of medicines called anti-infectives. Sulfonamide ophthalmic preparations are used to treat infections ...

  7. Liraglutide (Subcutaneous Route) Precautions - Mayo Clinic

    Other medicines—Do not take other medicines during the time you are using liraglutide unless they have been discussed with your doctor. This especially includes ...

  8. Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients - Mayo Clinic

    More data is needed to establish the safety and efficacy of these agents in the pretransplant and post-transplant settings.

  9. Spesolimab-Sbzo (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  10. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...